Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19185311 | 0.93 | MEN1 (0.33) | CA1CA2 | |
| SCHEMBL11597388 | 0.88 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL6577557 | 0.85 | DNM1 (0.43) | CA1CA2CYP3A4DNM1 | |
| SCHEMBL6577026 | 0.83 | DNM1 (0.40) | CYP3A4DNM1 | |
| SCHEMBL4425572 | 0.83 | CA1 (0.33) | CA1CA2 | |
| SCHEMBL4275678 | 0.81 | DNM1 (0.55) | CA1CA2DNM1 | |
| SCHEMBL8432808 | 0.81 | DNM1 (0.55) | CA1CA2DNM1 | |
| SCHEMBL1817035 | 0.81 | DNM1 (0.55) | CA1CA2DNM1 | |
| SCHEMBL4275158 | 0.81 | DNM1 (0.55) | CA1CA2DNM1 | |
| SCHEMBL4271916 | 0.81 | DNM1 (0.55) | CA1CA2DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0817776-B1 | FORMALDEHYDE-FREE 1,3,5-TRIAZINE BASED CROSSLINKERS | CYTEC TECH CORP (US) | 2004-05-06 | — | — | EP | disclosed |
| US-6613866-B2 | Monomeric and polymeric urethane surfactants which are derived from linear, branched or aromatic compounds of synthetic or natural origin, preferably from tertiary amines and diisocyante compounds; cosmetics, dental care, toiletries | ALZO INTERNATIONAL INC. | 2003-09-02 | — | — | US | disclosed |
| EP-1162949-A4 | URETHANE SURFACTANTS AND THEIR USE IN PERSONAL CARE FORMULATIONS | ALZO INC (US) | 2003-05-07 | — | — | EP | disclosed |
| US-20020015688-A1 | Urethane surfactants and their use in personal care formulations | ALZO, INC. | 2002-02-07 | — | — | US | disclosed |
| EP-1162949-A1 | URETHANE SURFACTANTS AND THEIR USE IN PERSONAL CARE FORMULATIONS | Alzo, Inc. (US) | 2001-12-19 | — | — | EP | disclosed |
| US-6315991-B1 | FOR USE IN COSMETICS, DENTAL CARE PRODUCTS AND TOILETRIES; FOR USE AS CONDITIONERS, ANTISTATS, DETANGLERS, FACILITATORS FOR EASE OF WET/DRY COMBING, AS EMULSIFIERS IN HAIR DYES | FLEET BANK, NATIONAL ASSOCIATION | 2001-11-13 | — | — | US | disclosed |
| WO-2000056285-A1 | URETHANE SURFACTANTS AND THEIR USE IN PERSONAL CARE FORMULATIONS | ALZO, INC. (US) | 2000-09-28 | — | — | WO | disclosed |
| US-5783642-A | Coating compositions containing 1,3,5-triazine compounds substituted with acetal and/or cyclized acetal-based groups | CYTEC INDUSTRIES INC. (US) | 1998-07-21 | — | — | US | disclosed |
| US-5777040-A | Curable compositions containing 1,3,5-triazine compounds substituted with acetal and/or cyclized acetal-based groups | CYTEC TECHNOLOGY CORP. (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0817776-A1 | FORMALDEHYDE-FREE 1,3,5-TRIAZINE BASED CROSSLINKERS | CYTEC TECHNOLOGY CORP. (US) | 1998-01-14 | — | — | EP | disclosed |
| US-5672703-A | CURING AGENTS | CYTEC TECHNOLOGY CORP. (US) | 1997-09-30 | — | — | US | disclosed |
| WO-1996029318-A1 | FORMALDEHYDE-FREE 1,3,5-TRIAZINE BASED CROSSLINKERS | CYTEC TECHNOLOGY CORP. (US) | 1996-09-26 | — | — | WO | disclosed |
| US-4118216-A | HERBICIDES | VELSICOL CHEMICAL COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-4097491-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020015688-A1 | Urethane surfactants and their use in personal care formulations | POLR1C, XRCC5, UROD | CA1 3483/4885CA2 2876/4885CYP3A4 3515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.